The Fundamental Adaptive Skills Training (FAST)

June 5, 2026 updated by: Norman Schmidt, Florida State University

Piloting and Evaluating the Fundamental Adaptive Skills Training (FAST): a New Digitally Augmented Single-Session Transdiagnostic Resilience Intervention

The present study seeks to develop, refine, and test a novel psychological treatment for boosting mental health resilience among college students. This Fundamental Adaptive Skills Training (FAST) will be evaluated in a randomized controlled trial. We will seek to recruit 5 undergraduate students as participants for a pilot phase and 100 undergraduate students for a randomized controlled trial. The primary questions we are seeking to answer in this trial are:

Do participants rate the FAST intervention as acceptable? Does FAST improve sleep quality, physical activity, anxiety sensitivity, loneliness, and social isolation for college students?

Participants will:

Receive the active FAST or a placebo control Relaxation and Mindfulness Training (RMT) and will complete measures at baseline, week 2, and week 4.

Study Overview

Detailed Description

The mental health crisis among college students has intensified in recent years, with rising rates of anxiety, depression, and stress. Despite increased institutional efforts, existing mental health services often remain inaccessible or insufficient. The present study proposes and evaluates the Fundamental Adaptive Skills Training (FAST), a novel, single-session intervention designed to promote mental health resilience in college students. FAST will be developed to target empirically supported mechanisms-sleep and physical activity, anxiety sensitivity, loneliness, and social isolation-each linked to a broad range of emotional disorders. Delivered in a digital, group-based format by trained undergraduate peer facilitators, FAST will be scalable, cost-effective, and engaging. This randomized controlled trial will assess the intervention's acceptability and efficacy in improving targeted mechanisms and reducing symptoms of anxiety, depression, and stress over a four-week follow-up period. 100 participants identified as at-risk based on elevated negative affectivity will be randomly assigned to FAST or an active control condition involving mindfulness and relaxation training (RMT). Primary outcomes include improvements in sleep quality, physical activity, anxiety sensitivity, loneliness, and social isolation from baseline through week two and week four follow-up. Similarly, clinical outcomes will include improvements in anxiety, depression, and stress levels as indicators of broader emotional resilience. Findings will advance the science of developing and implementing accessible, evidence-based mental health interventions and may contribute to a novel, scalable solution for addressing mental health issues in higher education settings.

Study Type

Interventional

Enrollment (Estimated)

105

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Florida
      • Tallahassee, Florida, United States, 32301
        • Recruiting
        • FSU Anxiety and Behavioral Health Clinic
        • Contact:
          • Frederick Schubert T Graduate Student, M.S.
          • Phone Number: 850-645-1766
          • Email: schubert@psy.fsu.edu
        • Principal Investigator:
          • Frederick Schubert T Graduate Student, M.S.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 18+
  • At-risk for emotional disorders as indicated by a PANAS-NA Score >= 20
  • Ability to use a computer or smartphone
  • Currently enrolled at college/university at the time of study enrollment

Exclusion criteria:

  • Adults aged 17 and under
  • PANAS-NA Score <= 19
  • Inability to use a computer or smartphone
  • Not currently enrolled at college/university at the time of study enrollment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fundamental Adaptive Skills Training
The FAST intervention will be approximately 60 minutes in duration. The video component of FAST, animated using the Vyond software, will be presented via computer or projector. Pause points and brief interactive exercises will be added throughout the presentation to promote engagement and ensure comprehension of FAST material. The treatment will be sectioned into thirds: a physical health section focused on sleep hygiene and physical activity, an anxiety sensitivity section dispelling common AS myths, and a social health section. Each section will contain brief psychoeducation focused on dispelling common myths or promoting adaptive skills use.
Other Names:
  • FAST
Active Comparator: Relaxation and Mindfulness Training
The RMT intervention will be primarily psychoeducational and focused on explaining relaxation methods used in various psychological treatments such as progressive muscle relaxation, guided imagery, and mindfulness-focused breathing exercises. Interactive relaxation and mindfulness exercises and brief discussions following each relaxation component will be included to control for time spent on interactive exercises in the FAST condition. The intervention will take approximately 60 minutes. Tailored to control for the effects of general education, practice exercises, and time spent on the FAST intervention, RMT will be a stronger control in comparison to a waitlist or repeated contact condition. Like the FAST intervention, this program will also be digitalized to allow for ease-of-administration.
Other Names:
  • RMT

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability Questionnaire
Time Frame: Post-intervention through week 4 follow up
Self report measure indexing intervention acceptability. Scores range from 0 to 27 with higher scores indicating more favorable acceptability.
Post-intervention through week 4 follow up
Athens Insomnia Scale
Time Frame: Baseline through week 4 follow up
8 item self report measure of sleep quality. Scores range from 0 to 24 with higher scores indicating more severe sleep problems.
Baseline through week 4 follow up
Brief Physical Activity Assessment Tool
Time Frame: Baseline through week 4 follow up
2 item self report measure indexing physical activity. Scores range from 0 to 8 with higher scores indicating more frequent engagement in physical activity.
Baseline through week 4 follow up
Anxiety Sensitivity Index 3
Time Frame: Baseline through week 4 follow up
18 item self report measure indexing anxiety sensitivity. Scores range from 0 to 72 with higher scores indicating more severe anxiety sensitivity.
Baseline through week 4 follow up
UCLA Loneliness 10
Time Frame: Baseline through week 4 follow up
10 item self-report measure indexing loneliness. Scores range from 10 to 40 with higher scores indicating more severe loneliness symptoms.
Baseline through week 4 follow up
PROMIS Anxiety Scale 8a
Time Frame: Baseline through week 4 follow up
8 item self report measure of anxiety. Scores range from 8 to 40 with higher scores indicating more severe anxiety symptoms.
Baseline through week 4 follow up
PROMIS Depression 8b
Time Frame: Baseline through week 4 follow up
8 item self report measure indexing depression. Scores range from 8 to 40 with higher scores indicating more severe depression symptoms
Baseline through week 4 follow up
Perceived Stress Scale
Time Frame: Baseline through week 4 follow up
14 item self report measure indexing stress. Scores range from 0 to 56 with higher scores reflecting more severe stress symptoms.
Baseline through week 4 follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Form 12
Time Frame: Baseline through week 4 follow up
Quality of life self report measure with 12 items. Scores range from 0 to 100 with higher scores indicating better quality of life
Baseline through week 4 follow up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Positive and Negative Affect Schedule - Negative Affect Scale
Time Frame: Screening through week 4 follow up
Self report measure indexing negative affectivity. Scores range from 10 to 40 with higher scores indicating worse negative affect.
Screening through week 4 follow up
Demographics
Time Frame: Baseline only
Self-report demographic questionnaire
Baseline only

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 20, 2025

Primary Completion (Estimated)

May 5, 2027

Study Completion (Estimated)

June 5, 2027

Study Registration Dates

First Submitted

August 22, 2025

First Submitted That Met QC Criteria

August 22, 2025

First Posted (Actual)

August 25, 2025

Study Record Updates

Last Update Posted (Actual)

June 8, 2026

Last Update Submitted That Met QC Criteria

June 5, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00006276

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fundamental Adaptive Skills Training

Clinical Trials on Fundamental Adaptive Skills Training

Subscribe